Jane Street’s Niagen Bioscience NAGE Stock Holding History

Jane Street’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Buy	282,900 +2,900	+1%	+$15.7K	﹤0.01%	6039
2025 Q4	$1.78M	Buy	+280,000	New	+$1.95M	﹤0.01%	5030
2025 Q3	–	Sell	-40,300	Closed	-$581K	–	12131
2025 Q2	$581K	Buy	+40,300	New	+$398K	﹤0.01%	6639
2021 Q4	–	Sell	-21,600	Closed	-$135K	–	10939
2021 Q3	$135K	Sell	21,600 -36,800	-63%	-$303K	﹤0.01%	9126
2021 Q2	$576K	Sell	58,400 -42,500	-42%	-$371K	﹤0.01%	6971
2021 Q1	$942K	Buy	+100,900	New	+$800K	﹤0.01%	5568

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's NAGE Position: Q1 2026 in Review

Jane Street sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 357,238 shares — an estimated $1.93M sold.

Jane Street first reported a position in NAGE in Q3 2018 and held it in 15 quarters. The position peaked at $2.27M in Q4 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Jane Street reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
Jane Street sold 357,238 Niagen Bioscience shares in Q1 2026, an estimated $1.93M.
Jane Street first reported a position in Niagen Bioscience in Q3 2018 and held it in 15 quarters.
Jane Street's Niagen Bioscience position peaked at $2.27M in Q4 2025.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.